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Abstract
Background: The long acting and permanent contraceptive methods (LAPCMs) has not used unlike that of short-acting
methods in Ethiopia. Ethiopia is the second most populous country in Sub Saharan Africa with a high total fertility rate,
and high maternal and child mortality rates. This study summarized the evidence of practice and intention to use long
acting and permanent family planning methods among women in Ethiopia using systemic review and meta-analysis.
Methods: A systematic review and meta-analysis of the published and unpublished observational studies were
conducted. Original studies were identified using databases of Medline/Pubmed, and Google Scholar. Heterogeneity
across studies was checked using Cochrane Q test statistic and I2test. The pooled proportion of intention to use and the
practice of long acting and permanent contraceptive methods were computed using a/the random effect model.
Results: Based on the ten observational studies included in the meta-analysis, the pooled prevalence of intention to use
long acting and permanent contraceptive methods among married women according to the random effect model was
42.98 % (95 % CI 32.53, 53.27 %). On the other hand, the pooled practice of long acting and permanent methods of
contraceptive among the study participants was 16.64 % (95 % CI 12.4 to 20.87 %).
Conclusion: This meta-analysis revealed that women’s intention to use LAPCMs is generally good but their utilization is
low. It is recommended, therefore, that LAPMCs must be made more readily available and accessible to women at the
lower level of health service delivery who are in need of it.
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Background
Family planning (FP) is a process that usually involves a
discussion between a woman, a man, and a trained FP
service provider focusing on family health and the
desires of the couple to either limit or space their
children [1]. Contraceptive methods used for FP can be
grouped programmatically into two categories. These are
long-acting and permanent contraceptive methods
(intrauterine devices, implants, and sterilization) and
short-term methods (pills, condoms, spermicides,
injectables, other modern methods, and all traditional
methods). Long-acting and permanent contraception
methods (LAPCMs) are generally used to limit child-
bearing, whereas short acting methods are important for
birth delay and birth spacing [2].
Researchers have shown that many women do not use
oral contraceptives correctly and consistently during
every act of sexual intercourse. As a result 1 million preg-
nancies occur from the faulty use of oral contraceptives
each year and unintended pregnancies remain common.
The method of contraception must be tailored to meet
the needs of such individuals [3, 4]. If more effective
LAPCMs were used, unintended births and induced
abortions could be substantively reduced to help families
and countries achieve their health goals [5]. Moreover,
removing barriers to the use of contraceptives and
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enhancing the demand for family planning could avert 54
million unintended pregnancies, more than 79,000
maternal deaths and 1 million infant deaths throughout
the world each year [6]. LAPCMs remain a relatively small
and sometimes missing component of national FP
programs in Sub Saharan Africa (SSA). These contracep-
tive methods have the potential to enhance FP programs
in meaningful ways if the challenges to their availability,
accessibility and acceptability can be overcome [3].
The total fertility rate of Ethiopia is 4.1 children per
woman. A great majority of the health facilities in
Ethiopia offer the oral contraceptive pill (98.8 %) and
injectable contraception (98.0 %) followed by the male
condom (95.2 %), an implant(75.0 %), an intra uterine
device (IUD) (53.6 %), female sterilization (22.6 %), male
sterilization (16.7 %), and the female condom (4.0 %) [6].
The modern contraceptive prevalence rate among
currently married women in Ethiopia is 40 %. Thirty
seven percent of married women want no more children
but only 3.4 % of married women reported using
implants, 0.3 % IUD, and less than 1 % are sterilized [7].
In a country like Ethiopia with a high fertility rate and
an unmet need of contraceptives, shifting towards
LAPCMs is an important strategy to ensure continuity of
the services. But the issue is controversial; the contracep-
tive method mix is dominated by short-term methods like
pills and injectables [8–11]. The Ethiopian Ministry of
Health has planned and has been working on the
provision of all FP methods, especially LAPCMs, in the
lowest service delivery level [12]. Despite the fact that
modern contraceptive services are made accessible nearly
all major urban areas in Ethiopia and in most instances at
lower or no cost but still not all women utilizing it [13].
Pocket studies in different part of Ethiopia were
conducted to estimate the magnitude of practice and
intention to use long acting and permanent contraceptive
methods among married women. These studies showed
that the intention to use long acting and permanent
contraceptive methods among married women ranges
from 27.3 % in Goba town, South East Ethiopia [8], to
65 % in Jinka town, Southern Ethiopia [14]. The practice
of LAPCMs among married women also ranged from
7.3 % in Jinka town, Southern Ethiopia [14], to 19.5 % in
Debre Markos town, North Ethiopia [15]. LAPCMs are
one of the key elements for the reduction of child and ma-
ternal mortality directly, and for achieving other MDG
goals indirectly.
It is important to have summarized evidence on the
practice rate and intention to use LAPCMs among
married women as this helps the concerned bodies to
identify existing gaps and propose supplementary
strategies to increase the availability, accessibility and
utilization of LAPCMs in Ethiopia. Therefore, the aim of
this study was to summarize the evidence of practice
and intention to use long acting and permanent family
planning methods among women in Ethiopia.
Methods
Study design and data source
This study was a systemic review and meta-analysis of
the published and unpublished observational studies on
prevalence rate of practice and intention to use
LAPCMs among married women in Ethiopia. English
language publications in the Medline data base, Google
Scholar and HINARI (Health Inter Network Access to
Research Initiative) were identified and cross-checked
with reference lists containing combinations of the key
words “intention to use” “demand” and “prevalence rate
of LAPCMs”. In addition, a search was also made for
cross-reference lists of identified original articles and
reviews for other relevant articles. The data abstraction
was performed from October 1 to June, 2015.
Study selection
A systematic review and meta-analysis were made on
cross-sectional studies that were focused on the
intention to use and practice of LAPCMs among mar-
ried women in Ethiopia. We included articles in the
meta-analysis if they reported the practice and/or
intention to use LAPCMs among married women in
Ethiopia without restriction of publication date. Reports
of original studies, unpublished master theses and PhD
dissertations which are written in English language were
also included. Studies were excluded from the analysis
for any of the following reasons: articles were focused on
short term contraceptives, meta-analysis or systematic
reviews; articles consisted of comments, editorials, or
duplicate publication of the same study; response rate
was less than 80 %, articles available only in abstract
form and articles with sample size of less than 50. The
selection of articles for review was done in three stages:
titles alone, abstracts, and then full-text articles.
Methodological quality assessment
Study quality indicators were sample size, reporting of
response rate and appraisal of external validity of the
study. Studies were assessed for quality and those with
high quality were included for analysis. High quality
studies were studies that: reported outcomes on at least
50 patients; had response rates greater than 80 %; and,
reported on either practice of LAPCMs and/or intention
to use LAPCMs.
Data abstraction
The data abstraction was conducted independently by
two investigators (YM, KT). The selected studies were
reviewed by using pretested and standardized abstraction
format and the following data were extracted: title,
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authors, year of publication, study site/base (community-
based or institution-based), sample size, response rates,
and measure of rate with its confidence interval (CI).
When there was a discrepancy in data abstraction between
the investigators, it was resolved through discussion and
consensus.
Statistical analysis
STATA version 11.0 software was used for data entry
and analysis. The descriptions of original studies were
made using tables and forest plots. The overall effect
(pooled estimated prevalence rate) of LAPCMs practice
and intention to use was carried out by using a random
effects model and measured by using a prevalence rate
with 95 % confidence intervals [95 % CI]. Heterogeneity
across studies was estimated by Cochran’s Q test [16]
and I2test which shows the proportion of total variation
across studies that is due to heterogeneity rather than to
chance [17].
Result
A total of 328 articles were identified through the litera-
ture search. Four additional articles were also manually
obtained. Of these 329 articles, 267 were excluded after
screening by titles and abstracts. These were duplicated
studies, case reports and reviews. Of the remaining 62
articles, 51 studies were excluded because 24 studies were
conducted outside Ethiopia, ten studies dealt with short
term contraceptive methods and 17 studies were based on
qualitative findings. Finally, 16 articles were used for the
meta-analysis with a total population of 18,569. Ten of the
articles were relevant for intention to use LAPCMs and
nine were relevant for practice. See Fig. 1 for the flow
diagram for the study selection.
Characteristics of studies included in the review
All of the 16 selected studies for the analysis were cross
sectional studies [7, 8, 11, 14, 15, 18–20, 22–28] con-
ducted between 2008 and 2015 with study populations
varying from 203 to 10,204. All studies were reported in
English. General characteristics and descriptions of the
studies selected for meta- analysis are outlined in Table 1.
Assessing heterogeneity
Ten studies dealing with intention to use LAPCMs
showed high heterogeneity using the Cochrane Q test
(Q test p = 0.0000) and I2 test (I2 = 99.1 %) which is
indicative for random effects modeling. Nine studies
which are included in this meta-analysis to pool the
practice of the married women towards LAPCMs also
showed high heterogeneity using Cochrane Q test (Q
test p = 0.0000) and I2 test (I2 = 95.0 %).
Fig. 1 Flow chart diagram describing selection of studies for the systematic review and meta-analysis (identification, screening, eligible and included
studies). Articles may have been excluded for more than one reason, 2015
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Table 1 Summary of the 16 observational studies included in the meta-analysis assessing women intention to use and practice of LAPCMs in Ethiopia, 2015
First author, year, Study period Study setting/base Study population Sample size Parameter studied Prevalence (%), Confidence interval
Gebremariam and Addissie [19], 2014 2012 Community based Married women of reproductive age 594 Intention to use LAPCMs 48.4 (44.1 - 52.7)
Takele et al. [8], 2014 2009 Community based Married women of reproductive age 734 Practice and intention to
use LAPCMs
8.7 (6.9 - 11)
27.3 (24.2 - 30.612)
Meskel and mekonene [18], 2014 2013 Health facility based Women who were using STCs 416 Intention to use LAPCMs 38 (33.3 - 42.7)
Bulto et al. [15], 2014 2012 Community based Married women of reproductive age 519 Practice and intention to
use LAPCMs
19.5 (16.3 - 23.1)
52.4 (48.1 - 56.7)
Getachew Mekonnen, [14] 2013 2008 Community based Women of reproductive age group 800 Practice and intention to
use LAPCMs
7.3 (5.7 - 9.3)
65.2 (61.9 - 68.5)
Haile A, Fantahun M, [22] 2012 Community based 398 Intention to use LAPCMs 24.4 (20.4 - 28.9)
EDHS [21], 2011 2010 Community based Married and sexually active unmarried
women
10,204 Intention to use LAPMCs 54.0 (53.0 - 55.0)
Dashe Negawo, unpublished [20] 2010 Health facility based Women who were using STCs 519 Intention to use LAPCMs 56.1 (51.8 - 60.3)
Alemayehu et al. [11], 2012 2012 Community based Married women of reproductive age 460 Practice of LAPMCs 12.3 (9.6 - 15.6)
Tesfaledet T, [23] 2015 2014 Community based Married women of reproductive age 802 Intention to use LAPCMs 18.2 (15.65 - 21)
Alemu S, [24] 2015 2014 Community based Married women of reproductive age 1003 Practice of LAPCMs 20 (17.65 - 22.6)
Walelgn G et al., 2015 (unpublished) [25] 2015 Community based Married women of reproductive age 662 Practice of LAPCMs 163 (13.5,19.1)
Haregewoyn K et al., 2015 (unpublished) [26] 2015 Community based women of reproductive age 393 Practice of LAPCMs 25.2 (21.0,29.5)
Wanzahun G et al. 2015 [27] 2015 Health facility based Women of reproductive age 203 Practice of LAPCMs 22.9 (17.1,28.7)
Amanuel A 2014 [28] 2014 Community based Married women of reproductive age 343 Intention to use LAPCMs 45.9 (40.6,51.2)














Intention to use long acting and permanent methods of
contraception
Among the 15 studies eligible for meta-analysis, ten
studies were focused on the intention of women to use
LAPCMs. A study in Jinka in South Ethiopia revealed
that nearly two thirds of participants had the intention
to use LAPCMs [14]. Another study from North West
Ethiopia in Debre Markos showed that 45.9 % of women
had the intention to use one of the LAPCMs in the fu-
ture. Of these, 98 (18.9 %) of the respondents intended
to use Implanon, 67 (12.9 %) Jadele, and 60 (11.6 %)
IUD [15]. A study in Wolayita, Southern Ethiopia,
reported tha t 38 % of women had the intention to use
LAPCMs [18].
According to a study conducted in Goba, South East
Ethiopia, the total demand for LAPCMs in the town was
18.12 %. The unmet need for LAPMCs was 9.4 %
(3.78 % for spacing children and 5.59 % for limiting
children). The overall prevalence rate of intention to use
LAPCMs in the study area was 27.3 % [8].
Another study conducted in Adigrat in the Tigray
region, North Ethiopia, showed that the prevalence of
intention to use LAPMCs was 48.4 % (95 % CI = 44.1,
52.7) while 14.6 % participants were unsure of their
intention. Of those who had intention, 58.9 % had
intention to use one of the LAPCMs within the next
1 year. The most preferred method participants ‘indi-
cated an intention to use was implants (71.3 %), followed
by IUCD (24.0 %). This study also demonstrated that
intention to use LAPCMs was higher among women who
knew at least one of LAPCMs (AOR= 4.7, 95 % CI = 1.58,
14.01) and women who do not want to have birth within
the next 2 years (AOR = 1.9, 95 % CI = 1.22, 3.13). The
intention to use LAPCMs was less among women who per-
ceive poor support from their husbands (AOR = 0.2, 95 %
CI = 0.09, 0.45) and those who perceive LAPCMs as harm-
ful to the womb (AOR= 0.24, 95 % CI = 0.14, 0.41) [19].
A study conducted in Ambo, Ethiopia, in 2010 docu-
mented that 291 (56.1 %) of 519 women who were using
family planning methods had the intention to use
LAPCMs [20]. Likewise, results from the Ethiopian
Demography and Health Survey in 2011 show that the
magnitude rate of intention to use among the study
population was 54 % [21]. On the other hand, the facility
based study conducted in East Showa Zone in Batu,
Ethiopia, in May 2009 showed that, among 398 women
aged 18 – 49 years, the magnitude rate of intention to
use LAPCMs was 24.4 % [22].
Based on ten observational studies included in the
meta-analysis, the pooled prevalence of intention to use
LAPCMs among married women according to the
random effect model was 42.98 % (95 % CI 32.53,
53.27 %) (Fig. 2).
Practices of LAPCMs among women of reproductive age
Of the 15 studies identified, 8 studies were dealing
with practice of women on LAPCMs. According to a
study from Jinka, South Ethiopia, the prevalence of
long acting and permanent contraceptive methods
was 7.3 %. About one out of every five participants
has ever received information about one or more of the
long acting and permanent contraceptive methods. In
addition, a study from Goba, South East Ethiopia, showed
the utilization of LAPCMs in the town as 8.7 % and the
unmet need for LAPCMs as 9.4 %. Moreover, according
to a study report from Mekelle, North Ethiopia, the overall
prevalence of long acting and permanent contraceptive
methods was 12.3 %. Of those married women who were
using LAPCMs, the majority of women (87 %) used im-
plants followed by IUCD (13 %), and there were no mar-
ried women who underwent female sterilization. Unlike
the previous three studies, a study from Debre Markos
Town, North West Ethiopia reported that 62.2 % of them
were using modern family planning (FP) methods in
which 19.5 % were using long acting and permanent
contraceptive methods (LAPCMs).
Based on the nine studies included in this meta-analysis,
the pooled practice prevalence rate of long acting and
permanent contraceptive methods among women was
16.64 % (95 % CI 12.4 to 20.87 %) (Fig. 3).
Discussion
The systemic review and meta-analysis targeted articles
on the magnitude of utilization and intention to use
(LAPCMs), with 15 studies selected. Fifteen studies were
identified from regional states of Ethiopia and one na-
tional survey [7]. The evidence was summarized in terms
of the magnitude of utilization and intention to use long
acting and permanent family planning method among
women in the reproductive age group. According to the
results of this meta-analysis, the pooled magnitude of
practice of and intention to use LAPCMs among women
in the reproductive age group were 16.64 and 42.98 %,
respectively.
Long-acting and permanent methods of contraception
(LAPCMs) can address a full range of women’s and
couples ‘family planning needs. According to the results
of this meta-analysis, the pooled magnitude of intention
to use LAPCMs among women in the reproductive age
group was 42.66 %. In the individual studies, the
intention to use LAPCMs among married women varied
from 18.2 % in a study conducted in East Wollega [23]
to 65.2 % in Jinka, Ethiopia [14]. This wide inter study
variation might be due to variations in settings and study
population.
Yet in Sub-Saharan Africa, only 2.7 million women or
fewer than one in eight (12.5 %) are currently using
these contraceptive methods. Likewise, these pooled
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studies in Ethiopia also showed that the practice of using
LAPMCs among women in the reproductive age group
was on average 13.5 % (8.2–18.74 %), which is low.
These low uptakes of LAPCMs might be due to the fact
that LAPCMs are provider dependent methods, which
are only available within the health care system (with
status of “health care system access”). The health care
system’s policies, structures and organization of services
and the providers’ practices greatly influence client
access to LAPCMs.
The meta-analysis revealed that there is a discrepancy
between intentions to use LAPCMs and practice. Even
though more proportions of married women had
intention to use LAPCMs (42.98 %), their actual practice
or utilization of LAPCMs was low (16.6 %). This implies
that there might be lack of accessibility and availability
of the LAPCMs in the lowest service delivery level near
to the residential area of the women. In Sub Saharan
Africa, the use of LAPCMs remains relatively low and
LAPCMs are sometimes the missing component of na-
tional FP programs [3]. A great majority of the health
facilities in Ethiopia offer oral pills (98.8 %) and in-
jectables (98.8 %) [6].
Strengths and limitations
The use of multiple data base for the researching of articles
(both manual and electronic search), abstraction of infor-
mation uniformly using a predetermined and pretested
Fig. 2 Forest Plot of the 10 Cross-Sectional Studies that quantitatively assessed the magnitude of intention to use long acting and permanent
family planning methods among married women in the reproductive age group, 2015
Fig. 3 Forest Plot of the 8 Cross-Sectional Studies that quantitatively assessed the prevalence rate of long acting and permanent family planning
methods practice among married women, 2015
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standard format by two independent reviewers can be
taken as strength of this study. There are potential limita-
tions to this study. The analysis was based on limited
studies conducted in subjects with different socio-cultural
and economical characteristics which might have effect on
women intention to use LAPCMs and their utilization.
Even though it incorporates 16 cross sectional studies from
different part of the country, still the representativeness of
the population is not as such strong.
Conclusions
The meta-analysis revealed that the intention of women
to use LAPCMs is generally good but the utilization of
LAPCMs by women is low. It is recommended that
LAPCMs must be made available and accessible for
those women who are in need of it at the lower health
service delivery level. In addition, client-provider inter-
action should be strengthened through empowering clients
and having skilled, motivated service providers with appro-
priately staffed, managed and functioning service sites.
Abbreviations
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